Advertisement

Topics

GlycoMimetics Reports Fourth Quarter and Year-End 2016 Results

09:30 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
GlycoMimetics, Inc. (NASDAQ: GLYC) today reported progress on its clinical development programs and its financial results for the fourth quarter and year ended December 31, 2016. “In 2016, GlycoMimetics made significa...

Other Sources for this Article

GlycoMimetics, Inc.
Investor Contact:
Shari Annes, 650-888-0902
sannes@annesassociates.com
or
Media Contact:
Jamie Lacey-Moreira, 410-299-3310
jamielacey@presscommpr.com

NEXT ARTICLE

More From BioPortfolio on "GlycoMimetics Reports Fourth Quarter and Year-End 2016 Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...